{
    "organizations": [],
    "uuid": "9d1f01eabc0142128dce8611db37c4c058bc2ed9",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-kadimastem-announces-the-enrollmen/brief-kadimastem-announces-the-enrollment-of-the-first-patient-for-its-clinical-trial-in-als-patients-idUSASC09XS2",
    "ord_in_thread": 0,
    "title": "Kadimastem Announces The Enrollment Of The First Patient For Its Clinical Trial In ALS Patients",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "April 26 (Reuters) - Kadimastem Ltd:\n* KADIMASTEM ANNOUNCES THE ENROLLMENT OF THE FIRST PATIENT FOR ITS CLINICAL TRIAL IN ALS PATIENTS\n* KADIMASTEM LTD - INTERIM RESULTS OF CLINICAL TRIAL IN ALS PATIENTS ARE EXPECTED WITHIN COMING YEAR Source text for Eikon:\n ",
    "published": "2018-04-26T21:12:00.000+03:00",
    "crawled": "2018-04-27T16:21:46.005+03:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "april",
        "reuters",
        "kadimastem",
        "ltd",
        "kadimastem",
        "announces",
        "enrollment",
        "first",
        "patient",
        "clinical",
        "trial",
        "al",
        "patient",
        "kadimastem",
        "ltd",
        "interim",
        "result",
        "clinical",
        "trial",
        "al",
        "patient",
        "expected",
        "within",
        "coming",
        "year",
        "source",
        "text",
        "eikon"
    ]
}